Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 6/2012

01-06-2012 | Letter to the Editor

Clinical response to thalidomide and colchicine in two siblings with Behcet’s disease carrying a single mutated MEFV allele

Authors: Donato Rigante, Francesco La Torre, Giuseppina Calcagno, Fernanda Falcini

Published in: Rheumatology International | Issue 6/2012

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Koné-Paut I, Sanchez E, Le Quellec A, Manna R, Touitou I (2007) Autoinflammatory gene mutations in Behçet’s disease. Ann Rheum Dis 66:832–834PubMedCrossRef
2.
Zierhut M, Mizuki N, Ohno S, Inoko H, Gül A, Onoé K, Isogai E (2003) Immunology and functional genomics of Behçet’s disease. Cell Mol Life Sci 60:1903–1922PubMedCrossRef
3.
Touitou I, Magne X, Molinari N, Navarro A, Quellec AL, Picco P, Seri M, Ozen S, Bakkaloglu A, Karaduman A, Garnier JM, Demaille J, Koné-Paut I (2000) MEFV mutations in Behçet’s disease. Hum Mutat 16:271–272PubMedCrossRef
4.
Rabinovich E, Shinar Y, Leiba M, Ehrenfeld M, Langevitz P, Livneh A (2007) Common FMF alleles may predispose to development of Behcet’s disease with increased risk for venous thrombosis. Scand J Rheumatol 36:48–52PubMedCrossRef
5.
Schwartz T, Langevitz P, Zemer D, Gazit E, Pras M, Livneh A (2000) Behçet’s disease in familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum 29:286–295PubMedCrossRef
6.
Livneh A, Aksentijevich I, Langevitz P, Torosyan Y, G-Shoham N, Shinar Y, Pras E, Zaks N, Padeh S, Kastner DL, Pras M (2001) A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet’s disease (FMF-BD). Eur J Hum Genet 9:191–196PubMedCrossRef
7.
Hamuryudan V, Hatemi G, Tascilar K, Sut N, Ozyazgan Y, Seyahi E, Mat C, Yurdakul S, Yazici H (2010) Prognosis of Behcet’s syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial. Rheumatology (Oxford) 49:173–177CrossRef
8.
Evereklioglu C (2004) Managing the symptoms of Behçet’s disease. Expert Opin Pharmacother 5:317–328PubMedCrossRef
Metadata
Title
Clinical response to thalidomide and colchicine in two siblings with Behcet’s disease carrying a single mutated MEFV allele
Authors
Donato Rigante
Francesco La Torre
Giuseppina Calcagno
Fernanda Falcini
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 6/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2046-0

Other articles of this Issue 6/2012

Rheumatology International 6/2012 Go to the issue

Original Article

Predictive factors related to progression toward rheumatoid arthritis in Korean patients with undifferentiated arthritis

Original Article

Antigen-induced arthritis in rabbits: a comparative study between high-resolution ultrasound and contrast-enhanced ultrasound and pathologic findings

Letter to the Editor

Pulmonary capillaritis leading to alveolar hemorrhage in a juvenile idiopathic arthritis patient: first description

Original Article

Intra-articular nodular fasciitis of the knee: a rare cause of recurrent hemarthrosis

Original Article

Small cell lung cancer presenting as dermatomyositis: mistaken for single connective tissue disease

Case Report

A case of rheumatoid arthritis presenting with postherpetic neuralgia and abdominal-wall pseudohernia
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits